Delaware | 1-10235 | 36-3555336 | ||
(State or other jurisdiction | (Commission File Number) | (IRS Employer | ||
of incorporation) | Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
(a) | Exhibits |
99.1 | Press release dated October 23, 2018 announcing IDEX Corporation’s quarterly operating results |
99.2 | Presentation slides of IDEX Corporation’s quarterly operating results |
IDEX CORPORATION | ||
By: | /s/ WILLIAM K. GROGAN | |
William K. Grogan | ||
Senior Vice President and Chief Financial Officer | ||
October 24, 2018 |
• | Orders were up 7 percent overall and 8 percent organically |
• | Sales were up 8 percent overall and 9 percent organically |
• | Reported operating margin was 23.3 percent with adjusted operating margin of 24.0 percent, up 200 bps |
• | Reported EPS was $1.37 with adjusted EPS of $1.41, up 31 percent |
“Continued strength across most end markets helped produce another quarter of excellent operating results for IDEX. Overall demand remained solid which helped deliver strong organic order and sales growth of 8 percent and 9 percent, respectively, our second consecutive quarter posting these organic growth rates. FMT and FSDP both achieved double-digit organic revenue growth rates, while HST realized mid-single digit organic revenue growth. Adjusted operating margin increased 200 basis points with robust margin expansion across all three segments. Third quarter adjusted EPS of $1.41 was a record and approximately 10 cents above the midpoint of our previous guidance, 6 cents of which was operational over-performance while 4 cents was due to a lower effective tax rate compared with our prior guidance. | |
We remain committed to fund our most encouraging organic opportunities across the Company, which was evidenced by record capital expenditures in the third quarter. This focus on organic growth has now led to nine consecutive quarters of organic order expansion and seven consecutive quarters of organic sales growth. M&A continues to be a top priority for the Company and the acquisition funnel is healthy. With gross debt-to-EBITDA of 1.3 times, our balance sheet stands ready and is able to support our disciplined capital deployment strategy. In the quarter, we distributed $33 million in dividends to shareholders and repurchased 210 thousand shares of common stock for approximately $31 million. | |
Based on our strong third quarter operating results, we are raising our full year organic revenue growth expectations to approximately 8 percent, with approximately 5 to 6 percent expected in the fourth quarter. We are also increasing full year EPS guidance to $5.35 to $5.37, with fourth quarter EPS of $1.25 to $1.27. Our EPS guidance assumes a higher than expected fourth quarter tax rate of 26 percent due to potential changes in certain assumptions associated with the 2017 tax reform.” | |
Andrew K. Silvernail | |
Chairman and Chief Executive Officer |
• | Sales of $239.2 million reflected an 8 percent increase compared to the third quarter of 2017 (+12 percent organic, -3 percent divestiture and -1 percent foreign currency translation). |
• | Operating income of $69.8 million resulted in an operating margin of 29.2 percent. Excluding $0.8 million of restructuring expenses, adjusted operating income was $70.6 million with an adjusted operating margin of 29.5 percent, a 140 basis point increase compared to the prior year period primarily due to higher volume and productivity initiatives. |
• | EBITDA of $74.8 million resulted in an EBITDA margin of 31.3 percent. Excluding $0.8 million of restructuring expenses, adjusted EBITDA of $75.6 million resulted in an adjusted EBITDA margin of 31.6 percent, an 80 basis point increase compared to the prior year period. |
• | Sales of $222.4 million reflected a 7 percent increase compared to the third quarter of 2017 (+6 percent organic, +2 percent acquisition and -1 percent foreign currency translation). |
• | Operating income of $49.1 million resulted in an operating margin of 22.1 percent. Excluding $3.1 million of restructuring expenses, adjusted operating income was $52.2 million with an adjusted operating margin of 23.5 percent, a 130 basis point increase compared to the prior year period primarily due to higher volume and productivity initiatives. |
• | EBITDA of $57.7 million resulted in an EBITDA margin of 26.0 percent. Excluding $3.1 million of restructuring expenses, adjusted EBITDA of $60.8 million resulted in an adjusted EBITDA margin of 27.4 percent, a 70 basis point decrease compared to the prior year period. |
• | Sales of $161.8 million reflected a 10 percent increase compared to the third quarter of 2017 (+11 percent organic and -1 percent foreign currency translation). |
• | Operating income of $44.7 million resulted in an operating margin of 27.6 percent. Excluding $0.1 million of restructuring expenses, adjusted operating income was $44.8 million with an adjusted operating margin of 27.7 percent, a 300 basis point increase compared to the prior year period primarily due to higher volume and productivity initiatives. |
• | EBITDA of $47.9 million resulted in an EBITDA margin of 29.6 percent. Excluding $0.1 million of restructuring expenses, adjusted EBITDA of $48.0 million resulted in an adjusted EBITDA margin of 29.7 percent, a 320 basis point increase compared to the prior year period. |
• | Organic orders and sales are calculated excluding amounts from acquired or divested businesses during the first twelve months of ownership or divestiture and the impact of foreign currency translation. |
• | Adjusted operating income is calculated as operating income plus restructuring expenses. |
• | Adjusted operating margin is calculated as adjusted operating income divided by net sales. |
• | Adjusted net income is calculated as net income plus restructuring expenses, net of the statutory tax expense or benefit. |
• | EBITDA is calculated as net income plus interest expense plus provision for income taxes plus depreciation and amortization. We reconciled EBITDA to net income on a consolidated basis as we do not allocate consolidated interest expense or consolidated provision for income taxes to our segments. |
• | Adjusted EBITDA is calculated as EBITDA plus restructuring expenses. |
• | Free cash flow is calculated as cash flow from operating activities less capital expenditures. |
Three Months Ended September 30, 2018 | Nine Months Ended September 30, 2018 | ||||||||||||||||||||||
FMT | HST | FSDP | IDEX | FMT | HST | FSDP | IDEX | ||||||||||||||||
Change in net sales | 8 | % | 7 | % | 10 | % | 8 | % | 8 | % | 10 | % | 12 | % | 10 | % | |||||||
- Net impact from acquisitions/divestitures | (3 | )% | 2 | % | — | % | — | % | (2 | )% | 1 | % | — | % | — | % | |||||||
- Impact from FX | (1 | )% | (1 | )% | (1 | )% | (1 | )% | 1 | % | 2 | % | 3 | % | 2 | % | |||||||
Change in organic net sales | 12 | % | 6 | % | 11 | % | 9 | % | 9 | % | 7 | % | 9 | % | 8 | % |
Three Months Ended September 30, | |||||||||||||||||||||||||||||||||||||||
2018 | 2017 | ||||||||||||||||||||||||||||||||||||||
FMT | HST | FSDP | Corporate | IDEX | FMT | HST | FSDP | Corporate | IDEX | ||||||||||||||||||||||||||||||
Reported operating income (loss) | $ | 69,755 | $ | 49,144 | $ | 44,726 | $ | (18,492 | ) | $145,133 | $ | 61,988 | $ | 46,073 | $ | 36,199 | $ | (17,756 | ) | $126,504 | |||||||||||||||||||
+ Restructuring expenses | 827 | 3,116 | 60 | 618 | 4,621 | — | — | — | — | — | |||||||||||||||||||||||||||||
Adjusted operating income (loss) | $ | 70,582 | $ | 52,260 | $ | 44,786 | $ | (17,874 | ) | $ | 149,754 | $ | 61,988 | $ | 46,073 | $ | 36,199 | $ | (17,756 | ) | $ | 126,504 | |||||||||||||||||
Net sales (eliminations) | $ | 239,213 | $ | 222,426 | $ | 161,832 | $ | (583 | ) | $ | 622,888 | $ | 220,953 | $ | 207,127 | $ | 146,599 | $ | (189 | ) | $ | 574,490 | |||||||||||||||||
Reported operating margin | 29.2 | % | 22.1 | % | 27.6 | % | n/m | 23.3 | % | 28.1 | % | 22.2 | % | 24.7 | % | n/m | 22.0 | % | |||||||||||||||||||||
Adjusted operating margin | 29.5 | % | 23.5 | % | 27.7 | % | n/m | 24.0 | % | 28.1 | % | 22.2 | % | 24.7 | % | n/m | 22.0 | % |
Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||||
2018 | 2017 | ||||||||||||||||||||||||||||||||||||||
FMT | HST | FSDP | Corporate | IDEX | FMT | HST | FSDP | Corporate | IDEX | ||||||||||||||||||||||||||||||
Reported operating income (loss) | $ | 207,149 | $ | 153,519 | $ | 130,162 | $ | (61,183 | ) | $ | 429,647 | $ | 179,830 | $ | 134,605 | $ | 106,022 | $ | (53,149 | ) | $ | 367,308 | |||||||||||||||||
+ Restructuring expenses | 1,313 | 5,298 | 427 | 1,213 | 8,251 | 1,566 | 3,028 | 73 | 130 | 4,797 | |||||||||||||||||||||||||||||
Adjusted operating income (loss) | $ | 208,462 | $ | 158,817 | $ | 130,589 | $ | (59,970 | ) | $ | 437,898 | $ | 181,396 | $ | 137,633 | $ | 106,095 | $ | (53,019 | ) | $ | 372,105 | |||||||||||||||||
Net sales (eliminations) | $ | 714,346 | $ | 670,904 | $ | 485,305 | $ | (983 | ) | $ | 1,869,572 | $ | 658,905 | $ | 611,215 | $ | 432,029 | $ | (741 | ) | $ | 1,701,408 | |||||||||||||||||
Reported operating margin | 29.0 | % | 22.9 | % | 26.8 | % | n/m | 23.0 | % | 27.3 | % | 22.0 | % | 24.5 | % | n/m | 21.6 | % | |||||||||||||||||||||
Adjusted operating margin | 29.2 | % | 23.7 | % | 26.9 | % | n/m | 23.4 | % | 27.5 | % | 22.5 | % | 24.6 | % | n/m | 21.9 | % |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Reported net income | $ | 106,352 | $ | 83,768 | $ | 312,436 | $ | 243,511 | |||||||
+ Restructuring expenses | 4,621 | — | 8,251 | 4,797 | |||||||||||
+ Tax impact on restructuring expenses | (1,130 | ) | — | (2,003 | ) | (1,529 | ) | ||||||||
Adjusted net income | $ | 109,843 | $ | 83,768 | $ | 318,684 | $ | 246,779 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Reported diluted EPS | $ | 1.37 | $ | 1.08 | $ | 4.02 | $ | 3.15 | |||||||
+ Restructuring expenses | 0.06 | — | 0.11 | 0.06 | |||||||||||
+ Tax impact on restructuring expenses | (0.02 | ) | — | (0.03 | ) | (0.02 | ) | ||||||||
Adjusted diluted EPS | $ | 1.41 | $ | 1.08 | $ | 4.10 | $ | 3.19 | |||||||
Diluted weighted average shares | 77,709 | 77,523 | 77,717 | 77,246 |
Three Months Ended September 30, | |||||||||||||||||||||||||||||||||||||||
2018 | 2017 | ||||||||||||||||||||||||||||||||||||||
FMT | HST | FSDP | Corporate | IDEX | FMT | HST | FSDP | Corporate | IDEX | ||||||||||||||||||||||||||||||
Reported operating income (loss) | $ | 69,755 | $ | 49,144 | $ | 44,726 | $ | (18,492 | ) | $ | 145,133 | $ | 61,988 | $ | 46,073 | $ | 36,199 | $ | (17,756 | ) | $ | 126,504 | |||||||||||||||||
- Other (income) expense - net | 411 | 780 | 342 | (599 | ) | 934 | 230 | (970 | ) | 1,044 | 1,349 | 1,653 | |||||||||||||||||||||||||||
+ Depreciation and amortization | 5,500 | 9,381 | 3,541 | 184 | 18,606 | 6,192 | 11,189 | 3,709 | 190 | 21,280 | |||||||||||||||||||||||||||||
EBITDA | 74,844 | 57,745 | 47,925 | (17,709 | ) | 162,805 | 67,950 | 58,232 | 38,864 | (18,915 | ) | 146,131 | |||||||||||||||||||||||||||
- Interest expense | 10,958 | 11,064 | |||||||||||||||||||||||||||||||||||||
- Provision for income taxes | 26,889 | 30,019 | |||||||||||||||||||||||||||||||||||||
- Depreciation and amortization | 18,606 | 21,280 | |||||||||||||||||||||||||||||||||||||
Reported net income | $ | 106,352 | $ | 83,768 | |||||||||||||||||||||||||||||||||||
Net sales (eliminations) | $ | 239,213 | $ | 222,426 | $ | 161,832 | $ | (583 | ) | $ | 622,888 | $ | 220,953 | $ | 207,127 | $ | 146,599 | $ | (189 | ) | $ | 574,490 | |||||||||||||||||
Reported operating margin | 29.2 | % | 22.1 | % | 27.6 | % | n/m | 23.3 | % | 28.1 | % | 22.2 | % | 24.7 | % | n/m | 22.0 | % | |||||||||||||||||||||
EBITDA margin | 31.3 | % | 26.0 | % | 29.6 | % | n/m | 26.1 | % | 30.8 | % | 28.1 | % | 26.5 | % | n/m | 25.4 | % |
Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||||
2018 | 2017 | ||||||||||||||||||||||||||||||||||||||
FMT | HST | FSDP | Corporate | IDEX | FMT | HST | FSDP | Corporate | IDEX | ||||||||||||||||||||||||||||||
Reported operating income (loss) | $ | 207,149 | $ | 153,519 | $ | 130,162 | $ | (61,183 | ) | $ | 429,647 | $ | 179,830 | $ | 134,605 | $ | 106,022 | $ | (53,149 | ) | $ | 367,308 | |||||||||||||||||
- Other (income) expense - net | 1,056 | (280 | ) | (3,324 | ) | (1,017 | ) | (3,565 | ) | 707 | 97 | 1,663 | (750 | ) | 1,717 | ||||||||||||||||||||||||
+ Depreciation and amortization | 16,901 | 30,860 | 10,912 | 557 | 59,230 | 17,823 | 34,447 | 10,938 | 598 | 63,806 | |||||||||||||||||||||||||||||
EBITDA | 222,994 | 184,659 | 144,398 | (59,609 | ) | 492,442 | 196,946 | 168,955 | 115,297 | (51,801 | ) | 429,397 | |||||||||||||||||||||||||||
- Interest expense | 33,098 | 33,920 | |||||||||||||||||||||||||||||||||||||
- Provision for income taxes | 87,678 | 88,160 | |||||||||||||||||||||||||||||||||||||
- Depreciation and amortization | 59,230 | 63,806 | |||||||||||||||||||||||||||||||||||||
Reported net income | $ | 312,436 | $ | 243,511 | |||||||||||||||||||||||||||||||||||
Net sales (eliminations) | $ | 714,346 | $ | 670,904 | $ | 485,305 | $ | (983 | ) | $ | 1,869,572 | $ | 658,905 | $ | 611,215 | $ | 432,029 | $ | (741 | ) | $ | 1,701,408 | |||||||||||||||||
Reported operating margin | 29.0 | % | 22.9 | % | 26.8 | % | n/m | 23.0 | % | 27.3 | % | 22.0 | % | 24.5 | % | n/m | 21.6 | % | |||||||||||||||||||||
EBITDA margin | 31.2 | % | 27.5 | % | 29.8 | % | n/m | 26.3 | % | 29.9 | % | 27.6 | % | 26.7 | % | n/m | 25.2 | % |
Three Months Ended September 30, | |||||||||||||||||||||||||||||||||||||||
2018 | 2017 | ||||||||||||||||||||||||||||||||||||||
FMT | HST | FSDP | Corporate | IDEX | FMT | HST | FSDP | Corporate | IDEX | ||||||||||||||||||||||||||||||
EBITDA | $ | 74,844 | $ | 57,745 | $ | 47,925 | $ | (17,709 | ) | $ | 162,805 | $ | 67,950 | $ | 58,232 | $ | 38,864 | $ | (18,915 | ) | $ | 146,131 | |||||||||||||||||
+ Restructuring expenses | 827 | 3,116 | 60 | 618 | 4,621 | — | — | — | — | — | |||||||||||||||||||||||||||||
Adjusted EBITDA | $ | 75,671 | $ | 60,861 | $ | 47,985 | $ | (17,091 | ) | $ | 167,426 | $ | 67,950 | $ | 58,232 | $ | 38,864 | $ | (18,915 | ) | $ | 146,131 | |||||||||||||||||
Adjusted EBITDA margin | 31.6 | % | 27.4 | % | 29.7 | % | n/m | 26.9 | % | 30.8 | % | 28.1 | % | 26.5 | % | n/m | 25.4 | % |
Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||||
2018 | 2017 | ||||||||||||||||||||||||||||||||||||||
FMT | HST | FSDP | Corporate | IDEX | FMT | HST | FSDP | Corporate | IDEX | ||||||||||||||||||||||||||||||
EBITDA | $ | 222,994 | $ | 184,659 | $ | 144,398 | $ | (59,609 | ) | $ | 492,442 | $ | 196,946 | $ | 168,955 | $ | 115,297 | $ | (51,801 | ) | $ | 429,397 | |||||||||||||||||
+ Restructuring expenses | 1,313 | 5,298 | 427 | 1,213 | 8,251 | 1,566 | 3,028 | 73 | 130 | 4,797 | |||||||||||||||||||||||||||||
Adjusted EBITDA | $ | 224,307 | $ | 189,957 | $ | 144,825 | $ | (58,396 | ) | $ | 500,693 | $ | 198,512 | $ | 171,983 | $ | 115,370 | $ | (51,671 | ) | $ | 434,194 | |||||||||||||||||
Adjusted EBITDA margin | 31.4 | % | 28.3 | % | 29.8 | % | n/m | 26.8 | % | 30.1 | % | 28.1 | % | 26.7 | % | n/m | 25.5 | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||
September 30, | June 30, | September 30, | |||||||||||||||||
2018 | 2017 | 2018 | 2018 | 2017 | |||||||||||||||
Cash flows from operating activities | $ | 133,327 | $ | 124,000 | $ | 120,697 | 325,753 | $ | 296,580 | ||||||||||
- Capital expenditures | 18,888 | 8,515 | 10,959 | 39,856 | 28,054 | ||||||||||||||
Free cash flow | $ | 114,439 | $ | 115,485 | $ | 109,738 | $ | 285,897 | $ | 268,526 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Net sales | $ | 622,888 | $ | 574,490 | $ | 1,869,572 | $ | 1,701,408 | |||||||
Cost of sales | 342,655 | 316,560 | 1,025,320 | 935,612 | |||||||||||
Gross profit | 280,233 | 257,930 | 844,252 | 765,796 | |||||||||||
Selling, general and administrative expenses | 130,479 | 131,426 | 406,354 | 393,691 | |||||||||||
Restructuring expenses | 4,621 | — | 8,251 | 4,797 | |||||||||||
Operating income | 145,133 | 126,504 | 429,647 | 367,308 | |||||||||||
Other (income) expense - net | 934 | 1,653 | (3,565 | ) | 1,717 | ||||||||||
Interest expense | 10,958 | 11,064 | 33,098 | 33,920 | |||||||||||
Income before income taxes | 133,241 | 113,787 | 400,114 | 331,671 | |||||||||||
Provision for income taxes | 26,889 | 30,019 | 87,678 | 88,160 | |||||||||||
Net income | $ | 106,352 | $ | 83,768 | $ | 312,436 | $ | 243,511 | |||||||
Earnings per Common Share: | |||||||||||||||
Basic earnings per common share | $ | 1.39 | $ | 1.09 | $ | 4.07 | $ | 3.19 | |||||||
Diluted earnings per common share | $ | 1.37 | $ | 1.08 | $ | 4.02 | $ | 3.15 | |||||||
Share Data: | |||||||||||||||
Basic weighted average common shares outstanding | 76,562 | 76,309 | 76,507 | 76,215 | |||||||||||
Diluted weighted average common shares outstanding | 77,709 | 77,523 | 77,717 | 77,246 |
September 30, 2018 | December 31, 2017 | ||||||
Assets | |||||||
Current assets | |||||||
Cash and cash equivalents | $ | 491,767 | $ | 375,950 | |||
Receivables - net | 324,895 | 294,166 | |||||
Inventories | 287,126 | 259,724 | |||||
Other current assets | 51,451 | 74,203 | |||||
Total current assets | 1,155,239 | 1,004,043 | |||||
Property, plant and equipment - net | 276,821 | 258,350 | |||||
Goodwill and intangible assets | 2,104,280 | 2,118,904 | |||||
Other noncurrent assets | 18,467 | 18,331 | |||||
Total assets | $ | 3,554,807 | $ | 3,399,628 | |||
Liabilities and shareholders' equity | |||||||
Current liabilities | |||||||
Trade accounts payable | $ | 141,178 | $ | 147,067 | |||
Accrued expenses | 185,453 | 184,705 | |||||
Short-term borrowings | 536 | 258 | |||||
Dividends payable | 33,046 | 28,945 | |||||
Total current liabilities | 360,213 | 360,975 | |||||
Long-term borrowings | 848,246 | 858,788 | |||||
Other noncurrent liabilities | 285,774 | 293,323 | |||||
Total liabilities | 1,494,233 | 1,513,086 | |||||
Shareholders' equity | 2,060,574 | 1,886,542 | |||||
Total liabilities and shareholders' equity | $ | 3,554,807 | $ | 3,399,628 |
Nine Months Ended September 30, | |||||||
2018 | 2017 | ||||||
Cash flows from operating activities | |||||||
Net income | $ | 312,436 | $ | 243,511 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation and amortization | 29,725 | 28,425 | |||||
Amortization of intangible assets | 29,505 | 35,381 | |||||
Amortization of debt issuance expenses | 998 | 989 | |||||
Share-based compensation expense | 19,814 | 18,143 | |||||
Deferred income taxes | (1,480 | ) | 1,888 | ||||
Non-cash interest expense associated with forward starting swaps | 4,869 | 5,004 | |||||
Changes in (net of the effect from acquisitions): | |||||||
Receivables | (34,057 | ) | (28,407 | ) | |||
Inventories | (27,903 | ) | (4,869 | ) | |||
Other current assets | 7,635 | (15,113 | ) | ||||
Trade accounts payable | (4,420 | ) | 3,681 | ||||
Accrued expenses | 33 | 9,912 | |||||
Other - net | (11,402 | ) | (1,965 | ) | |||
Net cash flows provided by operating activities | 325,753 | 296,580 | |||||
Cash flows from investing activities | |||||||
Purchases of property, plant and equipment | (39,856 | ) | (28,054 | ) | |||
Purchase of intellectual property | (4,000 | ) | — | ||||
Acquisition of businesses, net of cash acquired | (20,205 | ) | — | ||||
Proceeds from disposal of fixed assets | 211 | 5,159 | |||||
Other - net | (1,180 | ) | (337 | ) | |||
Net cash flows used in investing activities | (65,030 | ) | (23,232 | ) | |||
Cash flows from financing activities | |||||||
Borrowings under revolving credit facilities | — | 33,000 | |||||
Payments under revolving credit facilities | (11,128 | ) | (181,692 | ) | |||
Dividends paid | (94,913 | ) | (82,869 | ) | |||
Proceeds from stock option exercises | 26,793 | 18,980 | |||||
Purchases of common stock | (50,654 | ) | (22,650 | ) | |||
Shares surrendered for tax withholding | (11,260 | ) | (5,903 | ) | |||
Settlement of foreign exchange contracts | 6,593 | 4,406 | |||||
Net cash flows used in financing activities | (134,569 | ) | (236,728 | ) | |||
Effect of exchange rate changes on cash and cash equivalents | (10,337 | ) | 30,707 | ||||
Net increase (decrease) in cash | 115,817 | 67,327 | |||||
Cash and cash equivalents at beginning of year | 375,950 | 235,964 | |||||
Cash and cash equivalents at end of period | $ | 491,767 | $ | 303,291 |
Three Months Ended September 30, (a) | Nine Months Ended September 30, (a) | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Fluid & Metering Technologies | ||||||||||||||||
Net sales | $ | 239,213 | $ | 220,953 | $ | 714,346 | $ | 658,905 | ||||||||
Operating income (b) | 69,755 | 61,988 | 207,149 | 179,830 | ||||||||||||
Operating margin | 29.2 | % | 28.1 | % | 29.0 | % | 27.3 | % | ||||||||
EBITDA | $ | 74,844 | $ | 67,950 | $ | 222,994 | $ | 196,946 | ||||||||
EBITDA margin | 31.3 | % | 30.8 | % | 31.2 | % | 29.9 | % | ||||||||
Depreciation and amortization | $ | 5,500 | $ | 6,192 | $ | 16,901 | $ | 17,823 | ||||||||
Capital expenditures | 6,487 | 3,944 | 15,142 | 12,159 | ||||||||||||
Health & Science Technologies | ||||||||||||||||
Net sales | $ | 222,426 | $ | 207,127 | $ | 670,904 | $ | 611,215 | ||||||||
Operating income (b) | 49,144 | 46,073 | 153,519 | 134,605 | ||||||||||||
Operating margin | 22.1 | % | 22.2 | % | 22.9 | % | 22.0 | % | ||||||||
EBITDA | $ | 57,745 | $ | 58,232 | $ | 184,659 | $ | 168,955 | ||||||||
EBITDA margin | 26.0 | % | 28.1 | % | 27.5 | % | 27.6 | % | ||||||||
Depreciation and amortization | $ | 9,381 | $ | 11,189 | $ | 30,860 | $ | 34,447 | ||||||||
Capital expenditures | 8,614 | 3,015 | 17,296 | 11,489 | ||||||||||||
Fire & Safety/Diversified Products | ||||||||||||||||
Net sales | $ | 161,832 | $ | 146,599 | $ | 485,305 | $ | 432,029 | ||||||||
Operating income (b) | 44,726 | 36,199 | 130,162 | 106,022 | ||||||||||||
Operating margin | 27.6 | % | 24.7 | % | 26.8 | % | 24.5 | % | ||||||||
EBITDA | $ | 47,925 | $ | 38,864 | $ | 144,398 | $ | 115,297 | ||||||||
EBITDA margin | 29.6 | % | 26.5 | % | 29.8 | % | 26.7 | % | ||||||||
Depreciation and amortization | $ | 3,541 | $ | 3,709 | $ | 10,912 | $ | 10,938 | ||||||||
Capital expenditures | 3,787 | 1,506 | 7,232 | 4,178 | ||||||||||||
Corporate Office and Eliminations | ||||||||||||||||
Intersegment sales eliminations | $ | (583 | ) | $ | (189 | ) | $ | (983 | ) | $ | (741 | ) | ||||
Operating income (b) | (18,492 | ) | (17,756 | ) | (61,183 | ) | (53,149 | ) | ||||||||
EBITDA | (17,709 | ) | (18,915 | ) | (59,609 | ) | (51,801 | ) | ||||||||
Depreciation and amortization | 184 | 190 | 557 | 598 | ||||||||||||
Capital expenditures | — | 50 | 186 | 228 | ||||||||||||
Company | ||||||||||||||||
Net sales | $ | 622,888 | $ | 574,490 | $ | 1,869,572 | $ | 1,701,408 | ||||||||
Operating income | 145,133 | 126,504 | 429,647 | 367,308 | ||||||||||||
Operating margin | 23.3 | % | 22.0 | % | 23.0 | % | 21.6 | % | ||||||||
EBITDA | $ | 162,805 | $ | 146,131 | $ | 492,442 | $ | 429,397 | ||||||||
EBITDA margin | 26.1 | % | 25.4 | % | 26.3 | % | 25.2 | % | ||||||||
Depreciation and amortization (c) | $ | 18,606 | $ | 21,280 | $ | 59,230 | $ | 63,806 | ||||||||
Capital expenditures | 18,888 | 8,515 | 39,856 | 28,054 | ||||||||||||
Three Months Ended September 30, (a) | Nine Months Ended September 30, (a) | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
Fluid & Metering Technologies | ||||||||||||||||
Net sales | $ | 239,213 | $ | 220,953 | $ | 714,346 | $ | 658,905 | ||||||||
Adjusted operating income (b) | 70,582 | 61,988 | 208,462 | 181,396 | ||||||||||||
Adjusted operating margin | 29.5 | % | 28.1 | % | 29.2 | % | 27.5 | % | ||||||||
Adjusted EBITDA | $ | 75,671 | $ | 67,950 | $ | 224,307 | $ | 198,512 | ||||||||
Adjusted EBITDA margin | 31.6 | % | 30.8 | % | 31.4 | % | 30.1 | % | ||||||||
Depreciation and amortization | $ | 5,500 | $ | 6,192 | $ | 16,901 | $ | 17,823 | ||||||||
Capital expenditures | 6,487 | 3,944 | 15,142 | 12,159 | ||||||||||||
Health & Science Technologies | ||||||||||||||||
Net sales | $ | 222,426 | $ | 207,127 | $ | 670,904 | $ | 611,215 | ||||||||
Adjusted operating income (b) | 52,260 | 46,073 | 158,817 | 137,633 | ||||||||||||
Adjusted operating margin | 23.5 | % | 22.2 | % | 23.7 | % | 22.5 | % | ||||||||
Adjusted EBITDA | $ | 60,861 | $ | 58,232 | $ | 189,957 | $ | 171,983 | ||||||||
Adjusted EBITDA margin | 27.4 | % | 28.1 | % | 28.3 | % | 28.1 | % | ||||||||
Depreciation and amortization | $ | 9,381 | $ | 11,189 | $ | 30,860 | $ | 34,447 | ||||||||
Capital expenditures | 8,614 | 3,015 | 17,296 | 11,489 | ||||||||||||
Fire & Safety/Diversified Products | ||||||||||||||||
Net sales | $ | 161,832 | $ | 146,599 | $ | 485,305 | $ | 432,029 | ||||||||
Adjusted operating income (b) | 44,786 | 36,199 | 130,589 | 106,095 | ||||||||||||
Adjusted operating margin | 27.7 | % | 24.7 | % | 26.9 | % | 24.6 | % | ||||||||
Adjusted EBITDA | $ | 47,985 | $ | 38,864 | $ | 144,825 | $ | 115,370 | ||||||||
Adjusted EBITDA margin | 29.7 | % | 26.5 | % | 29.8 | % | 26.7 | % | ||||||||
Depreciation and amortization | $ | 3,541 | $ | 3,709 | $ | 10,912 | $ | 10,938 | ||||||||
Capital expenditures | 3,787 | 1,506 | 7,232 | 4,178 | ||||||||||||
Corporate Office and Eliminations | ||||||||||||||||
Intersegment sales eliminations | $ | (583 | ) | $ | (189 | ) | $ | (983 | ) | $ | (741 | ) | ||||
Adjusted operating income (b) | (17,874 | ) | (17,756 | ) | (59,970 | ) | (53,019 | ) | ||||||||
Adjusted EBITDA | (17,091 | ) | (18,915 | ) | (58,396 | ) | (51,671 | ) | ||||||||
Depreciation and amortization | 184 | 190 | 557 | 598 | ||||||||||||
Capital expenditures | — | 50 | 186 | 228 | ||||||||||||
Company | ||||||||||||||||
Net sales | $ | 622,888 | $ | 574,490 | $ | 1,869,572 | $ | 1,701,408 | ||||||||
Adjusted operating income | 149,754 | 126,504 | 437,898 | 372,105 | ||||||||||||
Adjusted operating margin | 24.0 | % | 22.0 | % | 23.4 | % | 21.9 | % | ||||||||
Adjusted EBITDA | $ | 167,426 | $ | 146,131 | $ | 500,693 | $ | 434,194 | ||||||||
Adjusted EBITDA margin | 26.9 | % | 25.4 | % | 26.8 | % | 25.5 | % | ||||||||
Depreciation and amortization (c) | $ | 18,606 | $ | 21,280 | $ | 59,230 | $ | 63,806 | ||||||||
Capital expenditures | 18,888 | 8,515 | 39,856 | 28,054 | ||||||||||||
(a) | Three and nine months data include the results of Finger Lakes Instrumentation (July 2018) and thinXXS (December 2017) in the Health & Science Technologies segment from the date of acquisition and the results of Faure Herman (October 2017) in the Fluid & Metering Technologies segment through the date of disposition. | |||||||||||||||
(b) | Segment operating income excludes unallocated corporate operating expenses which are included in Corporate Office and Eliminations. | |||||||||||||||
(c) | Depreciation and amortization excludes amortization of debt issuance costs. |